Mark O’Connor
Mahesh Makhijani
Ingo Thon
Oliver Boucher
Oliver Boucher has a successful track record creating and managing start-ups and executing strategic transactions at Board level on both the buy-side and sell-side of the life science business-to-business (B2B) market within the pharmaceutical and diagnostics industries. He also has significant experience in fund-raising, both dilutive and non-dilutive. He has held senior commercial and business roles in a succession of biotech companies after having gained executive level experience for seven years as a director of business development at GSK. Before joining industry, Oliver Boucher was a patent attorney in London, Montreal and Paris. He received an MA in genetics and molecular biology from Cambridge University and earned an MBA from INSEAD Business School. Mr Boucher joined Zoetis in 2017.